OKUR OnKure Therapeutics Inc: Company Short-Term Debts

Symbol and logo of brand OnKure (OKUR)

OnKure Therapeutics Inc (OKUR) generates revenue based on the market launch of targeted therapies for breast cancer (PI3Kalpha). Molecule synthesis is delegated to external contractors while the company retains full patent ownership. The volume of short-term liabilities reflects capital management dynamics, with the indicator standing at 0.00. Business stability is ensured by the development of the scientific foundation and the advancement of drugs through clinical trial stages in US laboratories.

OKUR onkuretherapeutics.com Company Short-Term Loans and Borrowings (10/08/2024 - 11/01/2026)

OKUR (OnKure Therapeutics, Inc.): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price OnKure|OKUR - Consensus Target
- company stock capitalization data:
Market Capitalization OnKure Therapeutics Inc|OKUR - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share OnKure Therapeutics|OKUR - Accounting Value of Company|Market Cap to Net Assets Ratio onkuretherapeutics.com|OKUR - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital OnKure Therapeutics Inc|OKUR - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio OnKure|OKUR - Company Aggregate Debts|Debt to Book Capitalization Ratio OnKure Therapeutics Inc|OKUR - Company Long-Term Loans and Borrowings|Company Short-Term Debts OnKure Therapeutics|Quick Liquidity onkuretherapeutics.com
- earnings and multiples data:
OKUR - Company Net Income
Analysis of all company metrics:OKUR - onkuretherapeutics.com
Manufactured products of OnKure Therapeutics Inc

For OnKure Therapeutics Inc (OKUR), which is developing a portfolio of inhibitors against solid tumors, short-term debt reflects the liquidity requirements necessary to maintain the operational cycle of clinical trials. An analysis of current short-term liabilities allows for an assessment of borrowings maturing within one year, alerting investors to potential interest overpayments and refinancing risks as biotechnological programs scale.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|Accuray Inc - Company Short-Term Loans and Borrowings|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Short-Term Debt Actuate Therapeutics Inc ACTU|Company Short-Term Debt Citius Oncology, Inc. (CTOR)|HURA - Short-Term Debt|Company Short-Term Debt Protara Therapeutics, Inc. TARA|FATE: Company Short-Term Indebtedness|WHWK - Company Short-Term Debt|TCRX - Company Short-Term Debts|CSBR (championsoncology.com) - Company Current Liabilities|XBiotech (XBIT) - Company Short-Term Debts|Company Short-Term Debt CEL-SCI Corp.|OSTX: Company Short-Term Loans and Borrowings|Company Short-Term Debts RADX|ARTV - Short-Term Debt|Adlai Nortye - Company Current Liabilities|Company Short-Term Loans and Borrowings VERU|TPST: Company Current Liabilities|Xilio Therapeutics, Inc. - Amount of Current Liabilities|RENB: Company Short-Term Debts|Mural Oncology - Company Short-Term Loans and Borrowings|KAPA (Kairos Pharma Limited) - Company Short-Term Debts|Short-Term Debt CytoMed GDTC|Company Short-Term Debt Curis, Inc. (CRIS)|APLM (apollomicsinc.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts THAR (Tharimmune Corp)|Company Short-Term Debts Advanced Biomed Inc. ADVB|GNPX - Company Short-Term Debt|Current Liabilities CLDI|SBFM: Company Short-Term Debts|Short-Term Debt Xenetic Biosciences, Inc. (XBIO)|Company Current Liabilities SLRX|Company Short-Term Debts Kitov Pharma|Company Current Liabilities AONC (American Oncology Network)|Amount of Current Liabilities BGNE|Company Short-Term Debts CKPT (Checkpoint Therapeutics, Inc.)|Short-Term Debt Volume Elevation Oncology Inc. (ELEV)|iCAD Corp - Company Short-Term Debts|Ikena Oncology, Inc. (IKNA) - Company Current Liabilities|Notable Labs, Ltd. (NTBL) - Company Short-Term Debt|VIRX - Short-Term Debt Volume|Company Current Liabilities MOR|NAYA: Company Short-Term Loans and Borrowings|Company Short-Term Debts AAPGV